Loading ...
the blood?s stem cellscausingreplacement of normal bone marrow tissue
to stimulate the regrowth of your actual bone(passive) is designedBone replacement material
if giving lower doses of chemotherapywill resultin successful bone marrow replacement
Proliferation of these cellscausesreplacement of normal bone
nonspecific signs and symptoms from the anemia , thrombocytopenia , and leukopeniaresultingfrom the replacement of bone marrow by leukemic cells
if giving lower doses of chemotherapy ( moderately ablativewill resultin successful bone marrow replacement
by calcium depletion(passive) caused bybone marrow loss
folate deficiency(passive) caused bymarrow megaloblastosis
Exposuremay causebone marrow changes
Treatment with methotrexate , etoposide , and cyclophosphamidemay causebone marrow changes
Follow - up Side effects Treatment with methotrexate , etoposide , and cyclophosphamidemay causebone marrow changes
This conditioncausesreplacement of bones
a new synthetic materialdesignedfor bone replacement
Preleukemia and Leukemia - Leukemia ... the bloodcausesWBCs to replace bone marrow
their activationcan leadto the replacement of bone marrow ( BM
to match these properties of the cortical bone as closely as possible(passive) should be designedA bone replacement
Cytopeniacan resultfrom marrow replacement and hypersplenism
EBMdesignedfor bone replacement
High Lumenleddownlight replacement
the bone marrowresultsin replacement of the bone marrow
3W 30 High Lumenleddownlight replacement
a stem cell transplantdesignedto replace her bone marrow
by vein wall ischemia with loss of smooth muscle cells(passive) is caused byMedial fibrous replacement
place ... the bloodcausesbone marrow to be replaced by leukocyte
thrombocytopeniaresultingfrom marrow replacement
other drugscauseBONE MARROW TRANSPLANT
THERAPYcausesBONE MARROW TRANSPLANT
AZATHIOPRINE ... other drugscauseBONE MARROW TRANSPLANT
bone marrow transplant patientscausingmarrow suppression
PREDNISONE ... other drugscauseBONE MARROW TRANSPLANT
not AZATHIOPRINEcausesBONE MARROW TRANSPLANT
by chemotherapy(passive) caused bymarrow suppression
chemotherapeutic agentscausingmarrow suppression
by radiation(passive) caused bymarrow suppression
originally(passive) was ... designedEndoprosthetic replacement
by azathioprine(passive) caused bymarrow suppression
by anticancer agents(passive) caused bymarrow suppression
Bilirubinaemia , anaemiacan ... resultmarrow transplant
cellular elementscomposedmarrow transplantation
donor - recipient matching for HLA(passive) is influenced bymarrow transplantation
anemia , thrombocytopenia , and neutropeniacausinganemia , thrombocytopenia , and neutropenia
The low signal intensity(passive) is caused byThe low signal intensity
of a synthetic powder which is mixed with a solution to form a pastecomposedof a synthetic powder which is mixed with a solution to form a paste
cytopeniascausescytopenias
in a , , and normalresultsin a , , and normal
The symptoms of AML(passive) are caused byThe symptoms of AML
in anemia and weaknessmay resultin anemia and weakness
impairment in hematologic functionmay causeimpairment in hematologic function
to osteoporosis and fracturescan leadto osteoporosis and fractures
to a net bone loss of bone tissueleadingto a net bone loss of bone tissue
Lesions(passive) are caused byLesions
weakness and susceptibilitycausingweakness and susceptibility
of purecomposed exclusivelyof pure
in Anemiaresultingin Anemia
neutropeniacausingneutropenia
weight loss in leptin deficient animalscausesweight loss in leptin deficient animals
to a recovery in Dr. Menonmay leadto a recovery in Dr. Menon
to increased risk of disseminationhas ledto increased risk of dissemination
from diseases such as osteoporosisresultingfrom diseases such as osteoporosis
bulbsDo ... ledbulbs
to anemia , leukopenia , and thrombocytopenialeadsto anemia , leukopenia , and thrombocytopenia
in chronic anemiaresultingin chronic anemia
local necrosiscan causelocal necrosis
problemscausingproblems
in weakening of the abscess cavityresultingin weakening of the abscess cavity
of cardiac toxicitymay causeof cardiac toxicity
to a decrease in both platelet count and neutrophil countleadingto a decrease in both platelet count and neutrophil count
in an estimate of the probability of developing this complication of 48 %resultingin an estimate of the probability of developing this complication of 48 %
to immunotherapyleadingto immunotherapy
usuallyresultsusually
to decreased hemoglobin production , retention of mitochondria , and apoptosisleadsto decreased hemoglobin production , retention of mitochondria , and apoptosis
you back close to $ 350 , 000 in americamight setyou back close to $ 350 , 000 in america